People News

Share this article:

Following its acquisition of Genentech, Roche has announced that Pascal Soriot, currently head of Roche's commercial pharmaceutical operations, will become Genentech's CEO, effective May 1, 2009. Soriot succeeds Arthur Levinson, chairman and CEO of Genentech since 1995. Levinson will retain his position as chairman.

 

Alnara Pharmaceuticals, a pharma manufacturer focused on the treatment of metabolic diseases, announced the promotion of Robert Gallotto to chief business officer. Gallotto was previously SVP, operations and corporate development.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.